INO Earnings INOVIO PHARMACEUTICALS, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.28 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -1.81 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -2.12 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.12 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.51 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -3.95 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -3.35 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.48 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.31 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -6.09 | 2025-03-18 | 10-K |
| Q3 2024 | 2023-09-30 | -5.01 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.50 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.89 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -14.07 | 2024-03-06 | 10-K |
| Q3 2023 | 2022-09-30 | -0.96 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.83 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.36 | 2023-05-10 | 10-Q |
| FY 2023 | 2021-12-31 | -17.45 | 2024-03-06 | 10-K |
| Q3 2022 | 2021-09-30 | -0.95 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.66 | 2022-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.